Squamous cell carcinoma and Crohn's disease: a sometimes-challenging diagnosis

Squamous cell carcinoma and Crohn's disease: a sometimes-challenging diagnosis

Aim: Non-melanoma skin cancers are more common in people with inflammatory bowel disease. However, these tumors can rarely mimic a cutaneous manifestation of the disease, which delays diagnosis and clouds prognosis. Observation: A 35-year-old man with stenosing and fistulizing ileocolic Crohn's...

Full description

Bibliographic Details
Main Authors:	Mona Boudabbous, Baha Barkia, Wiem Feki, Héla Gdoura, Lassad Chtourou, Manel Moalla, Leila Mnif, Ali Amouri, Zeinab Mnif, Nabil Tahri
Format:	Article
Language:	English
Published:	Future Science Ltd 2023-12-01
Series:	Future Science OA
Subjects:	combination therapy inflammatory bowel disease squamous cell carcinoma thiopurines
Online Access:	https://www.future-science.com/doi/10.2144/fsoa-2023-0109

Similar Items

Alexithymia impairs quality of life in irritable bowel syndrome
by: Mona Boudabbous, et al.
Published: (2023-12-01)

A survey to explore the psychological and professional impact of change imposed by COVID-19
by: Mona Boudabbous, et al.
Published: (2023-09-01)

Screening for renal impairment in viral hepatopathy B: it is time to begin
by: Mona Boudabbous, et al.
Published: (2023-10-01)

Incidence of Myelotoxicity and Other Adverse Effects Related to Thiopurine Starting in Patients with Inflammatory Bowel Disease: Retrospective Observational Study in a Third-Level Hospital
by: Gerard Grau, et al.
Published: (2023-10-01)

Use of Thiopurines in Inflammatory Bowel Disease: A Consensus Statement by the Korean Association for the Study of Intestinal Diseases (KASID)
by: Kang-Moon Lee, et al.
Published: (2015-07-01)

Improved HPLC Quantification of 6-Mercaptopurine Metabolites in Red Blood Cells: Monitoring Data and Literature Analysis
by: Tiphaine Adam de Beaumais, et al.
Published: (2022-10-01)

Severe Complication of Thiopurine Treatment in a Young Woman with Crohn’s Disease
by: Michiel PJ Voet, et al.
Published: (2021-03-01)

Efficacy of Thiopurines in Biologic-Naive Japanese Patients With Crohn's Disease: A Single-Center Experience
by: Takuya Yoshino, et al.
Published: (2015-07-01)

Clinical Presentation, Management, and Evolution of Lymphomas in Patients with Inflammatory Bowel Disease: An ENEIDA Registry Study
by: Ivan Guerra, et al.
Published: (2023-01-01)

Risk-stratified monitoring for thiopurine toxicity in immune-mediated inflammatory diseases: prognostic model development, validation, and, health economic evaluationResearch in context
by: Georgina Nakafero, et al.
Published: (2023-10-01)

Epstein-Barr Virus Infection and Thiopurine Therapy in a Pediatric Population with Inflammatory Bowel Disease
by: Maria Do Céu Espinheira, et al.
Published: (2020-04-01)

Long-term efficacy and tolerability of dose-adjusted thiopurine treatment in maintaining remission in inflammatory bowel disease patients with heterozygosity
by: Takato Maeda, et al.
Published: (2022-01-01)

Therapeutic role of methotrexate in pediatric Crohn’s disease
by: Zlatko Djurić, et al.
Published: (2018-08-01)

Hepatosplenic T-Cell Lymphoma: A Rare Complication of Monotherapy with Thiopurines in Crohn’s Disease
by: Joana Carvão, et al.
Published: (2018-11-01)

Cytotoxicity of Thiopurine Drugs in Patients with Inflammatory Bowel Disease
by: Oliwia Zakerska-Banaszak, et al.
Published: (2022-03-01)

Epstein–Barr Virus Prevalence at Diagnosis and Seroconversion during Follow-Up in Pediatric Inflammatory Bowel Disease
by: Jennifer Bachmann, et al.
Published: (2021-11-01)

Plasma lipidomic profiling of thiopurine-induced leukopenia after NUDT15 genotype-guided dosing in Chinese IBD patients
by: Pan Li, et al.
Published: (2023-06-01)

NUDT15, FTO, and RUNX1 genetic variants and thiopurine intolerance among Japanese patients with inflammatory bowel diseases
by: Toshiyuki Sato, et al.
Published: (2017-07-01)

Immunomodulatory therapy in paediatric inflammatory bowel disease
by: András Arató
Published: (2013-10-01)

Nudix Hydroxylase 15 Mutations Strongly Predict Thiopurine-Induced Leukopenia Across Different Asian Ethnicities: Implications for Screening in a Diverse Population
by: Xin-Hui Khoo, et al.
Published: (2022-08-01)

Exclusive enteral nutrition with concomitant early thiopurine use was effective in maintaining steroid-free remission in a Southeast Asian cohort of children with Crohn’s disease
by: Christina Ong, et al.
Published: (2018-12-01)

The Role of Pharmacogenetics in the Therapeutic Response to Thiopurines in the Treatment of Inflammatory Bowel Disease: A Systematic Review
by: Aline C. Ribeiro, et al.
Published: (2023-10-01)

Clinical utility of thiopurine metabolite monitoring in inflammatory bowel disease and its impact on healthcare utilization in Singapore
by: Jia Qi Yeo, et al.
Published: (2022-10-01)

Impact of Duodenal Pathology on Oral Drug Bioavailability and Disease Outcomes in Pediatric Crohn’s Disease
by: Rebecca Casini, et al.
Published: (2023-02-01)

Taking Crohn’s Disease Personally
by: Yehuda Chowers
Published: (2013-04-01)

Implications of Tioguanine Dosing in IBD Patients with a TPMT Deficiency
by: Debbie S. Deben, et al.
Published: (2023-10-01)

Can We Predict the Toxicity and Response to Thiopurines in Inflammatory Bowel Diseases?
by: Raphael P. Luber, et al.
Published: (2019-11-01)

Pregnancy outcome in women with inflammatory bowel disease treated with anti-tumor necrosis factor and/or thiopurine therapy: a multicenter study from Japan
by: Shunsuke Komoto, et al.
Published: (2016-04-01)

Population-Specific Distribution of TPMT Deficiency Variants and Ancestry Proportions in Ecuadorian Ethnic Groups: Towards Personalized Medicine
by: Gallardo-Cóndor J, et al.
Published: (2023-11-01)

Azathioprine‐induced severe myelosuppression accompanied by massive hair loss and painful oral ulcer in an autoimmune hepatitis patient with NUDT15 minor variant: A case report
by: Yu Takeuchi, et al.
Published: (2021-08-01)

Eosinophilic enteritis accompanied by cytomegalovirus disease: a case report
by: Yuichi Yamaga, et al.
Published: (2022-04-01)

Efficacy and Safety of Long-Term Thiopurine Maintenance Treatment in Japanese Patients With Ulcerative Colitis
by: Satoshi Yamada, et al.
Published: (2015-07-01)

Myeloid neoplasms in inflammatory bowel disease: A case series and review of the literature
by: David M. Mueller, et al.
Published: (2024-01-01)

Pharmacokinetic Profiling and Simultaneous Determination of Thiopurine Immunosuppressants and Folic Acid by Chromatographic Methods
by: Edvin Brusač, et al.
Published: (2019-09-01)

Hipertensión portal idiopática por tiopurinas
by: Salvador Machlab, et al.

Thiopurines: Recent Topics and Their Role in the Treatment of Inflammatory Bowel Diseases
by: Keiichi Tominaga, et al.
Published: (2021-01-01)

Capillary Electrophoresis Hyphenated with Mass Spectrometry for Determination of Inflammatory Bowel Disease Drugs in Clinical Urine Samples
by: Katarína Maráková, et al.
Published: (2017-11-01)

A Validated HPLC–Diode Array Detection Method for Therapeutic Drug Monitoring of Thiopurines in Pediatric Patients: From Bench to Bedside
by: Martina Franzin, et al.
Published: (2022-11-01)

Thiopurines’ Metabolites and Drug Toxicity: A Meta-Analysis
by: Paula Sousa, et al.
Published: (2020-07-01)

Azathioprine‐induced pancytopenia: A case report
by: Keshav Raj Sigdel, et al.
Published: (2022-09-01)